These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27999163)

  • 21. Bivalent oral cholera vaccination induces a memory B cell response to the V. cholerae O1-polysaccharide antigen in Haitian adults.
    Falkard B; Charles RC; Matias WR; Mayo-Smith LM; Jerome JG; Offord ES; Xu P; Kováč P; Ryan ET; Qadri F; Franke MF; Ivers LC; Harris JB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007057. PubMed ID: 30703094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.
    Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET
    Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh.
    Patel SM; Rahman MA; Mohasin M; Riyadh MA; Leung DT; Alam MM; Chowdhury F; Khan AI; Weil AA; Aktar A; Nazim M; LaRocque RC; Ryan ET; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2012 Jun; 19(6):842-8. PubMed ID: 22518009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
    Sayeed MA; Bufano MK; Xu P; Eckhoff G; Charles RC; Alam MM; Sultana T; Rashu MR; Berger A; Gonzalez-Escobedo G; Mandlik A; Bhuiyan TR; Leung DT; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Vann WF; Kováč P; Ryan ET
    PLoS Negl Trop Dis; 2015; 9(7):e0003881. PubMed ID: 26154421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
    Haney DJ; Lock MD; Gurwith M; Simon JK; Ishioka G; Cohen MB; Kirkpatrick BD; Lyon CE; Chen WH; Sztein MB; Levine MM; Harris JB
    Vaccine; 2018 May; 36(20):2768-2773. PubMed ID: 29655627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic determinants of the cholera/coli family of enterotoxins.
    Finkelstein RA; Burks MF; Zupan A; Dallas WS; Jacob CO; Ludwig DS
    Rev Infect Dis; 1987; 9 Suppl 5():S490-502. PubMed ID: 2446368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
    Leung DT; Uddin T; Xu P; Aktar A; Johnson RA; Rahman MA; Alam MM; Bufano MK; Eckhoff G; Wu-Freeman Y; Yu Y; Sultana T; Khanam F; Saha A; Chowdhury F; Khan AI; Charles RC; Larocque RC; Harris JB; Calderwood SB; Kovác P; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2013 Jun; 20(6):780-8. PubMed ID: 23515016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.
    Chac D; Bhuiyan TR; Saha A; Alam MM; Salma U; Jahan N; Chowdhury F; Khan AI; Ryan ET; LaRocque R; Harris JB; Qadri F; Weil AA
    Infect Immun; 2021 Aug; 89(9):e0021721. PubMed ID: 34228490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.
    Baranova DE; Willsey GG; Levinson KJ; Smith C; Wade J; Mantis NJ
    Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32589220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh.
    Kendall EA; Tarique AA; Hossain A; Alam MM; Arifuzzaman M; Akhtar N; Chowdhury F; Khan AI; Larocque RC; Harris JB; Ryan ET; Qadri F; Calderwood SB
    Infect Immun; 2010 Jan; 78(1):253-9. PubMed ID: 19858296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
    Bishop AL; Schild S; Patimalla B; Klein B; Camilli A
    Infect Immun; 2010 Oct; 78(10):4402-20. PubMed ID: 20679439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.
    Ryan ET; Crean TI; John M; Butterton JR; Clements JD; Calderwood SB
    Infect Immun; 1999 Apr; 67(4):1694-701. PubMed ID: 10085006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
    Levinson KJ; Giffen SR; Pauly MH; Kim DH; Bohorov O; Bohorova N; Whaley KJ; Zeitlin L; Mantis NJ
    J Immunol Methods; 2015 Jul; 422():111-7. PubMed ID: 25865265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh.
    Harris JB; Podolsky MJ; Bhuiyan TR; Chowdhury F; Khan AI; Larocque RC; Logvinenko T; Kendall J; Faruque AS; Nagler CR; Ryan ET; Qadri F; Calderwood SB
    PLoS Negl Trop Dis; 2009; 3(3):e403. PubMed ID: 19333369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.
    Hossain M; Islam K; Kelly M; Mayo Smith LM; Charles RC; Weil AA; Bhuiyan TR; Kováč P; Xu P; Calderwood SB; Simon JK; Chen WH; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Leung DT; Azman AS; Harris JB; Qadri F; Ryan ET
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007874. PubMed ID: 31743334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.
    Weil AA; Ellis CN; Debela MD; Bhuiyan TR; Rashu R; Bourque DL; Khan AI; Chowdhury F; LaRocque RC; Charles RC; Ryan ET; Calderwood SB; Qadri F; Harris JB
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434744
    [No Abstract]   [Full Text] [Related]  

  • 38. Cross-protection against Vibrio cholerae infection by monoclonal antibodies against Vibrio vulnificus RtxA1/MARTX
    Lee TH; Cha SS; Lee CS; Rhee JH; Woo HR; Chung KM
    Microbiol Immunol; 2016 Nov; 60(11):793-800. PubMed ID: 27921342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholera: Immunity and Prospects in Vaccine Development.
    Harris JB
    J Infect Dis; 2018 Oct; 218(suppl_3):S141-S146. PubMed ID: 30184117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.
    Alam MM; Bufano MK; Xu P; Kalsy A; Yu Y; Freeman YW; Sultana T; Rashu MR; Desai I; Eckhoff G; Leung DT; Charles RC; LaRocque RC; Harris JB; Clements JD; Calderwood SB; Qadri F; Vann WF; Kováč P; Ryan ET
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2683. PubMed ID: 24516685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.